Research
Comparison of three different anti-Xa assays in major orthopedic surgery patients treated with direct oral anticoagulant
Published on: 12 October 2017
Featured article: The CD31 molecule: a possible neuroprotective agent in acute ischemic stroke?
The transmembrane receptor molecule CD31 is known to have immunomodulatory functions, suggesting a possible neuroprotective effect in the context of acute ischemic stroke by restricting an over-activation of secondary immunological processes. This study examines the density of CD31+ cells in mechanically extracted thrombi of stroke patients with the aim to test whether the occurrence of CD31+ cells was associated with a beneficial clinical outcome in those patients.
World Thrombosis Day: preventing thrombosis and promoting high quality of life
October 13th is World Thrombosis Day, a global movement that aims to focus attention on thrombosis, an often overlooked and misunderstood condition. To mark the occasion we invited Tetsumei Urano, an Associate Editor for Thrombosis Journal to tells us about the conditions that the day focuses on.
Articles
-
-
Research
Treatment with direct oral anticoagulants in patients with upper extremity deep vein thrombosis
Published on: 3 October 2017
-
Research
The risk of venous thromboembolism associated with peripherally inserted central catheters in ambulant cancer patients
Published on: 19 September 2017
-
Research
-
Case report
Dabigatran reversal with idarucizumab in a patient undergoing heart transplantation: first European report
Published on: 5 September 2017
-
Review
Laboratory assessment of rivaroxaban: a review
Published on: 3 July 2013
-
Original clinical investigation
-
Review
Practical management of patients on apixaban: a consensus guide
Published on: 31 December 2013
-
Review
The role of prothrombin complex concentrates in reversal of target specific anticoagulants
Published on: 17 April 2014
-
Review
Heparin-induced thrombocytopenia: an update
Published on: 4 October 2005
Aims and scope
Thrombosis Journal is an open-access journal that publishes original articles on aspects of clinical and basic research, new methodology, case reports and reviews in the areas of thrombosis.
Topics of particular interest include the diagnosis of arterial and venous thrombosis, new antithrombotic treatments, new developments in the understanding, diagnosis and treatments of atherosclerotic vessel disease, relations between haemostasis and vascular disease, hypertension, diabetes, immunology and obesity.
Ask the experts: what is venous thromboembolic disease?
Recognized on 13 October, World Thrombosis Day seeks to increase global awareness of thrombosis. In appreciation of this day, we asked representatives from Thrombosis Journal, the Asian-Pacific Society of Thrombosis and Haemostasis (APSTH) and the International Society on Thrombosis and Haemostasis (ISTH) to share their knowledge of the condition.
Latest article series and supplements
The 9th Congress of the Asian-Pacific Society on Thrombosis and Hemostasis was held from 6-9 October 2016 in Taipei, Taiwan.
As the official journal of the APSTH, Thrombosis Journal has published a supplement of state of the art review and research articles in conjunction with the congress.
Inflammation and its role in thrombosis
In recent years it has become increasingly clear that the immune system and coagulation pathways interact and influence one another. Inflammation-induced thrombosis is considered a feature of several autoimmune diseases and thus such findings have important consequences for the treatment and management of such diseases.
Editors' quotes
"Open access is a critical element in dissemination of knowledge and research data throughout the world. In the field of thrombosis and haemostasis many developments are relevant, not only for the developed world, but also for those in underdeveloped nations where access to journals may be limited. The strength of Thrombosis Journal is that is can be accessed by everyone, everywhere. I strongly encourage scientists to submit their valuable data (clinical and basic research) to Thrombosis Journal, where we provide a platform for the full range of thrombosis and haemostasis related topics (also including case reports and special issue contributions)."
Hugo ten Cate, Editor-in-Chief, Thrombosis Journal
"Treatment and prophylaxis of thrombotic and bleeding disorders is of great importance to the worldwide population, and there is a great need to facilitate the research activities related to this field. The aim of Thrombosis Journal is to provide a platform on which these important studies are visible to all members of the scientific community and public."
Yukio Ozaki, Editor-in-Chief, Thrombosis Journal
Advertisement
